HepaRegeniX GmbH Files Patent Application for 3-Benzoyl-1H-Pyrrolo[2,3-B]Pyridine Derivatives As Mkk4 Inhibitors for Treating Liver Diseases
In: Indian Patents News (India), 2022-12-07, S. 2
Zeitungsartikel
Zugriff:
Kolkata, Dec. 7 -- Germany-based HepaRegeniX GmbH filed patent application for 3-benzoyl-1h-pyrrolo[2,3-b]pyridine derivatives as mkk4 inhibitors for treating liver diseases. The inventors are Selig Roland, Laufer Stefan and Albrecht Wolfgang. HepaRegeniX GmbH filed the patent application on July 21, 2022. The patent application number is 202247041748 A. The international classification numbers are C07D0471040000, C07F0007080000, A61K0031505000, A61P0001160000 and A61K0031501000...
Titel: |
HepaRegeniX GmbH Files Patent Application for 3-Benzoyl-1H-Pyrrolo[2,3-B]Pyridine Derivatives As Mkk4 Inhibitors for Treating Liver Diseases
|
---|---|
Zeitschrift: | Indian Patents News (India), 2022-12-07, S. 2 |
Veröffentlichung: | 2022 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|